SEC Info - Om Group Inc - ‘10-K’ for 12/31/10

SEC Info℠

Home

Help

Please Sign In

Om Group Inc – ‘10-K’ for 12/31/10 – ‘XML.R19’

On: Thursday, 2/24/11, at 3:27pm ET · For: 12/31/10 · Accession #: 950123-11-17806 · File #: 1-12515

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/24/11  Om Group Inc                      10-K       12/31/10   54:7.6M                                   Donnelley … Solutions/FA

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.34M 
 2: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     77K 
 4: EX-10.12    Material Contract                                     13     69K 
 5: EX-10.13    Material Contract                                     12     55K 
 6: EX-10.14    Material Contract                                      5     34K 
 7: EX-10.19    Material Contract                                   HTML     32K 
 8: EX-10.20    Material Contract                                   HTML     37K 
 9: EX-10.33    Material Contract                                   HTML     78K 
 3: EX-10.7     Material Contract                                     91    205K 
10: EX-21       Subsidiaries List                                   HTML     20K 
11: EX-23       Consent of Experts or Counsel                       HTML     20K 
12: EX-24       Power of Attorney                                   HTML     26K 
13: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
14: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
15: EX-32       Certification -- §906 - SOA'02                      HTML     17K 
44: XML         IDEA XML File -- Definitions and References          XML    109K 
50: XML         IDEA XML File -- Filing Summary                      XML     83K 
48: XML.R1      Document and Entity Information                      XML    206K 
49: XML.R2      Consolidated Balance Sheets                          XML    405K 
30: XML.R3      Consolidated Balance Sheets (Parenthetical)          XML    141K 
36: XML.R4      Statements of Consolidated Operations                XML    487K 
42: XML.R5      Statements of Consolidated Comprehensive Income      XML    174K 
                (Loss)                                                           
41: XML.R6      Statements of Consolidated Cash Flows                XML    612K 
53: XML.R7      Statements of Consolidated Total Equity              XML   1.43M 
26: XML.R8      Statements of Consolidated Total Equity              XML     50K 
                (Parenthetical)                                                  
40: XML.R9      Significant Accounting Policies                      XML     70K 
25: XML.R10     Recently Issued Accounting Guidance                  XML     45K 
24: XML.R11     Inventories                                          XML     46K 
29: XML.R12     Property, Plant and Equipment, net                   XML     50K 
46: XML.R13     Acquisition                                          XML     56K 
31: XML.R14     Goodwill and Other Intangible Assets                 XML    150K 
32: XML.R15     Restructuring                                        XML     84K 
38: XML.R16     Discontinued Operations                              XML     48K 
54: XML.R17     Debt                                                 XML     46K 
28: XML.R18     Derivative Instruments                               XML    131K 
22: XML.R19     Fair Value Disclosures                               XML     75K 
34: XML.R20     Income Taxes                                         XML    137K 
45: XML.R21     Pension and other Post-Retirement Benefit Plans      XML    266K 
27: XML.R22     Accumulated Other Comprehensive Income (Loss)        XML     66K 
43: XML.R23     Earnings Per Share                                   XML     76K 
33: XML.R24     Share-Based Compensation                             XML    133K 
52: XML.R25     Commitments and Contingencies                        XML     47K 
47: XML.R26     Lease Obligations                                    XML     45K 
37: XML.R27     Reportable Segments and Geographic Information       XML    146K 
39: XML.R28     Quarterly Results of Operations (Unaudited)          XML    120K 
23: XML.R29     Valuation and Qualifying Accounts                    XML     89K 
51: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.11M 
16: EX-101.INS  XBRL Instance -- omg-20101231                        XML   1.36M 
18: EX-101.CAL  XBRL Calculations -- omg-20101231_cal                XML    157K 
21: EX-101.DEF  XBRL Definitions -- omg-20101231_def                 XML     68K 
19: EX-101.LAB  XBRL Labels -- omg-20101231_lab                      XML    536K 
20: EX-101.PRE  XBRL Presentations -- omg-20101231_pre               XML    322K 
17: EX-101.SCH  XBRL Schema -- omg-20101231                          XSD     68K 
35: ZIP         XBRL Zipped Folder -- 0000950123-11-017806-xbrl      Zip    115K

‘XML.R19’ — Fair Value Disclosures

This Financial Report is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

<ReportLongName> 0211 - Disclosure - Fair Value Disclosures </ReportLongName>

<ShowElementNames> false </ShowElementNames>

<HasEmbeddedReports> false </HasEmbeddedReports>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<LabelColumn> false </LabelColumn>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

<MCU>

<KeyName> 1/1/2010 - 12/31/2010 USD ($) / shares USD ($) </KeyName>

<PeriodType> duration </PeriodType>

</contextRef>

<UPS>

<UnitID> USDEPS </UnitID>

<UnitType> Divide </UnitType>

</NumeratorMeasure>

<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>

<MeasureValue> shares </MeasureValue>

<MeasureNamespace> xbrli </MeasureNamespace>

</DenominatorMeasure>

</UnitProperty>

<UnitType> Standard </UnitType>

</StandardMeasure>

</UnitProperty>

<UnitID> Shares </UnitID>

<UnitType> Standard </UnitType>

<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>

<MeasureValue> shares </MeasureValue>

<MeasureNamespace> xbrli </MeasureNamespace>

</StandardMeasure>

</UnitProperty>

</UPS>

</MCU>

</Labels>

</Column>

</Columns>

<Rows>

<Row>

<ElementName> us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract </ElementName>

<PeriodType> duration </PeriodType>

<ShortDefinition> No definition available. </ShortDefinition>

<IsReportTitle> false </IsReportTitle>

<IsSegmentTitle> false </IsSegmentTitle>

<IsSubReportEnd> false </IsSubReportEnd>

<IsCalendarTitle> false </IsCalendarTitle>

<IsTuple> false </IsTuple>

<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>

<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>

<IsBeginningBalance> false </IsBeginningBalance>

<IsEndingBalance> false </IsEndingBalance>

<IsReverseSign> false </IsReverseSign>

<Cells>

<Cell>

<IsNumeric> false </IsNumeric>

<IsRatio> false </IsRatio>

<DisplayZeroAsNone> false </DisplayZeroAsNone>

<IsIndependantCurrency> false </IsIndependantCurrency>

<ShowCurrencySymbol> false </ShowCurrencySymbol>

<DisplayDateInUSFormat> false </DisplayDateInUSFormat>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

</Cell>

</Cells>

<Unit> Other </Unit>

<ElementDataType> xbrli:stringItemType </ElementDataType>

<SimpleDataType> string </SimpleDataType>

<ElementDefenition> No definition available. </ElementDefenition>

<IsTotalLabel> false </IsTotalLabel>

<IsEPS> false </IsEPS>

<Label> Fair Value Disclosures [Abstract] </Label>

</Row>

<Row>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<ElementName> us-gaap_FairValueMeasurementInputsDisclosureTextBlock </ElementName>

<PeriodType> duration </PeriodType>

<ShortDefinition> No definition available. </ShortDefinition>

<IsReportTitle> false </IsReportTitle>

<IsSegmentTitle> false </IsSegmentTitle>

<IsSubReportEnd> false </IsSubReportEnd>

<IsCalendarTitle> false </IsCalendarTitle>

<IsTuple> false </IsTuple>

<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>

<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>

<IsBeginningBalance> false </IsBeginningBalance>

<IsEndingBalance> false </IsEndingBalance>

<IsReverseSign> false </IsReverseSign>

<PreferredLabelRole> verboselabel </PreferredLabelRole>

<Cells>

<Cell>

<IsNumeric> false </IsNumeric>

<IsRatio> false </IsRatio>

<DisplayZeroAsNone> false </DisplayZeroAsNone>

<div style="margin-left: 0%"> <div style="margin-top: 12pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> <b><font style="font-family: Arial, Helvetica">Note 11 — Fair Value Disclosures</font></b> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> The following table shows the Company’s assets and liabilities accounted for at fair value on a recurring basis: </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <table border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: Arial, Helvetica; color: #000000; background: transparent; text-align: left">  <tr style="font-size: 1pt" valign="bottom"> <td width="38%"> </td> <td width="1%"> </td> <td width="1%" align="right"> </td> <td width="13%" align="right"> </td> <td width="1%" align="left"> </td> <td width="1%"> </td> <td width="1%" align="right"> </td> <td width="12%" align="right"> </td> <td width="1%" align="left"> </td> <td width="1%"> </td> <td width="1%" align="right"> </td> <td width="12%" align="right"> </td> <td width="1%" align="left"> </td> <td width="1%"> </td> <td width="1%" align="right"> </td> <td width="13%" align="right"> </td> <td width="1%" align="left"> </td> </tr>   <tr style="font-size: 7pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td> </td> <td colspan="10" align="center" valign="bottom" style="border-bottom: 1px solid #000000"> <b>Fair Value Measurements at Reporting Date Using</b> </td> <td> </td> </tr> <tr style="font-size: 7pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Quoted Prices in<br /> </b> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> </tr> <tr style="font-size: 7pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Active Markets for<br /> </b> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Significant Other<br /> </b> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Significant<br /> </b> </td> <td> </td> </tr> <tr style="font-size: 7pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Identical Assets<br /> </b> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Observable Inputs<br /> </b> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Unobservable Inputs<br /> </b> </td> <td> </td> </tr> <tr style="font-size: 7pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom" style="border-bottom: 1px solid #000000"> <b>Description</b> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom" style="border-bottom: 1px solid #000000"> <b>December 31, 2010</b> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom" style="border-bottom: 1px solid #000000"> <b>(Level 1)</b> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom" style="border-bottom: 1px solid #000000"> <b>(Level 2)</b> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom" style="border-bottom: 1px solid #000000"> <b>(Level 3)</b> </td> <td> </td> </tr> <tr style="line-height: 3pt; font-size: 1pt"> <td> </td> </tr>  <tr valign="bottom" style="background: #cceeff"> <td nowrap="nowrap" align="left" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt"> <b>Liabilities:</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> </tr> <tr valign="bottom"> <td nowrap="nowrap" align="left" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt"> <b>Commodity contracts</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>$</b> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>(378</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>)</b> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> $ </td> <td nowrap="nowrap" align="right" valign="bottom"> — </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>$</b> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>(378</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>)</b> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> $ </td> <td nowrap="nowrap" align="right" valign="bottom"> — </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> </tr> <tr valign="bottom" style="background: #cceeff"> <td align="left" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt"> <b>Interest rate swap agreements</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>(393</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>)</b> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> — </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>(393</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>)</b> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> — </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> </tr> <tr valign="bottom" style="font-size: 1pt"> <td> </td> <td> </td> <td style="border-top: 1px solid #000000"> </td> <td style="border-top: 1px solid #000000"> </td> <td> </td> <td> </td> <td style="border-top: 1px solid #000000"> </td> <td style="border-top: 1px solid #000000"> </td> <td> </td> <td> </td> <td style="border-top: 1px solid #000000"> </td> <td style="border-top: 1px solid #000000"> </td> <td> </td> <td> </td> <td style="border-top: 1px solid #000000"> </td> <td style="border-top: 1px solid #000000"> </td> <td> </td> </tr> <tr valign="bottom"> <td nowrap="nowrap" align="left" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt"> <b>Total</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>$</b> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>(771</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>)</b> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> $ </td> <td nowrap="nowrap" align="right" valign="bottom"> — </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>$</b> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>(771</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>)</b> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> $ </td> <td nowrap="nowrap" align="right" valign="bottom"> — </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> </tr> <tr valign="bottom" style="font-size: 1pt"> <td> </td> <td> </td> <td style="border-top: 3px double #000000"> </td> <td style="border-top: 3px double #000000"> </td> <td> </td> <td> </td> <td style="border-top: 3px double #000000"> </td> <td style="border-top: 3px double #000000"> </td> <td> </td> <td> </td> <td style="border-top: 3px double #000000"> </td> <td style="border-top: 3px double #000000"> </td> <td> </td> <td> </td> <td style="border-top: 3px double #000000"> </td> <td style="border-top: 3px double #000000"> </td> <td> </td> </tr> </table> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> See Note 13 for fair value disclosure related to pension assets. </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> The Company uses significant other observable inputs to value commodity contracts and interest rate swap agreements; therefore, they are classified within Level 2 of the valuation hierarchy. The fair value for these contracts is determined based on copper prices and interest rates, respectively. There were no transfers into or out of Levels 1, 2 or 3 in 2010. </div>  </div>   <div style="margin-left: 0%">  <div align="left" style="margin-left: 0%; margin-right: 0%; font-size: 12pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> <b> <font style="font-family: Arial, Helvetica"> </font> </b> <font style="font-size: 10pt"> <font style="font-family: Arial, Helvetica"> </font> </font> <i> <font style="font-size: 10pt; font-family: 'Times New Roman', Times"> </font> </i> </div>  <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> Cobalt forward purchase contracts are classified as Level 3, as their valuation is based on the expected future cash flows discounted to present value. Future cash flows are estimated using a theoretical forward price as quoted forward prices are not available. The following table provides a reconciliation of derivatives measured at fair value on a recurring basis which used Level 3 inputs: </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <table border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent; text-align: left">  <tr style="font-size: 1pt" valign="bottom"> <td width="85%"> </td> <td width="2%"> </td> <td width="1%" align="right"> </td> <td width="11%" align="right"> </td> <td width="1%" align="left"> </td> </tr>   <tr style="font-size: 8pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Fair Value<br /> </b> </td> <td> </td> </tr> <tr style="font-size: 8pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Measurements<br /> </b> </td> <td> </td> </tr> <tr style="font-size: 8pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Using<br /> </b> </td> <td> </td> </tr> <tr style="font-size: 8pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Significant<br /> </b> </td> <td> </td> </tr> <tr style="font-size: 8pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Unobservable<br /> </b> </td> <td> </td> </tr> <tr style="font-size: 8pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Inputs<br /> </b> </td> <td> </td> </tr> <tr style="font-size: 8pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom" style="border-bottom: 1px solid #000000"> <b>(Level 3)</b> </td> <td> </td> </tr> <tr style="font-size: 8pt" valign="bottom" align="center"> <td nowrap="nowrap" align="center" valign="bottom"> </td> <td> </td> <td colspan="2" nowrap="nowrap" align="center" valign="bottom"> <b>Derivatives</b> </td> <td> </td> </tr> <tr style="line-height: 3pt; font-size: 1pt"> <td> </td> </tr>  <tr valign="bottom" style="background: #cceeff"> <td nowrap="nowrap" align="left" valign="bottom"> <div style="text-indent: -10pt; margin-left: 10pt"> <b>January 1, 2009</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>$</b> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>(57</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>)</b> </td> </tr> <tr valign="bottom"> <td align="left" valign="bottom"> <div style="text-indent: -10pt; margin-left: 10pt"> <b>Realized gains (losses) included in earnings</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>227</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> </tr> <tr valign="bottom" style="background: #cceeff"> <td align="left" valign="bottom"> <div style="text-indent: -10pt; margin-left: 10pt"> <b>Purchases, issuances, and settlements</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>(170</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>)</b> </td> </tr> <tr valign="bottom"> <td align="left" valign="bottom"> <div style="text-indent: -10pt; margin-left: 10pt"> <b>Transfers in and/or out of Level 3</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>—</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> </tr> <tr valign="bottom" style="font-size: 1pt"> <td> </td> <td> </td> <td style="border-top: 1px solid #000000"> </td> <td style="border-top: 1px solid #000000"> </td> <td> </td> </tr> <tr valign="bottom" style="background: #cceeff"> <td nowrap="nowrap" align="left" valign="bottom"> <div style="text-indent: -10pt; margin-left: 10pt"> <b>December 31, 2009</b> </div> </td> <td> </td> <td nowrap="nowrap" align="left" valign="bottom"> <b>$</b> </td> <td nowrap="nowrap" align="right" valign="bottom"> <b>—</b> </td> <td nowrap="nowrap" align="left" valign="bottom"> </td> </tr> <tr valign="bottom" style="font-size: 1pt"> <td> </td> <td> </td> <td style="border-top: 3px double #000000"> </td> <td style="border-top: 3px double #000000"> </td> <td> </td> </tr> </table> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> </div> <div style="margin-top: 12pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> <u><font style="font-family: Arial, Helvetica">Non-recurring fair value measurements</font></u> </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> In September 2009, the Company announced a restructuring plan related to its Advanced Organics business. See Note 7. As a result, the Company reviewed its long-lived assets associated with the Manchester, England facility for impairment and recorded a $5.7 million impairment charge. The fair value measurements were calculated using significant unobservable inputs (combination of the cost and market approach). </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> In accordance with the provisions of the “Intangibles — Goodwill and Other” topic of the ASC, goodwill of the UPC reporting unit was written down to its implied fair value of $28.3 million after completing step two in 2009. The resulting $4.1 million adjustment to the estimated goodwill impairment charge of $8.8 million recorded in 2008 was included in earnings of 2009. During 2009, the Company recorded an additional $15.8 million goodwill impairment charge related to the UPC reporting unit to write down goodwill with a carrying value of $28.5 million to its implied fair value of $12.7 million. In addition, the Company recorded an impairment charge of $19.1 million related to the Photomasks reporting unit to write down goodwill with a carrying value of $22.3 million to its implied fair value of $3.2 million. Goodwill related to the Advanced Organics reporting unit with a carrying amount of $6.8 million was written down to its implied fair value of $0, resulting in an impairment charge of $6.8 million in 2009. The Company utilizes a discounted cash flow analysis to estimate the fair value of the reporting units utilizing unobservable inputs. The fair value measurement of the reporting unit under the step-one analysis and the step-two analysis in their entirety are classified as Level 3 inputs. </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> During 2009 the Company also wrote down to fair value indefinite-lived trade name intangible assets in its Photomasks and Electronic Chemicals reporting units and a license agreement in its UPC reporting unit due to downward revisions in estimates of future revenue and cash flows. The impaired indefinite-lived trade name intangible assets were determined to have an estimated fair value of $4.0 million resulting in a charge of $0.7 million, and the license agreement was determined to have no value resulting in a charge of $0.9 million. Both charges were included in earnings for 2009. The Company utilizes a “relief from royalty” methodology in estimating fair values for indefinite-lived trade names. The methodology estimates the fair value of each trade name by determining the present value of the royalty payments that are avoided as a result of owning the trade name and includes judgmental assumptions about sales growth that are consistent with the assumptions used to determine the fair value of reporting units in the Company’s goodwill testing. The fair value measurements were calculated using unobservable inputs, classified as Level 3, requiring significant management judgment due to the absence of quoted market prices or observable inputs for assets of a similar nature. </div>  </div>   <div style="margin-left: 0%">  <div align="left" style="margin-left: 0%; margin-right: 0%; font-size: 12pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> <b> <font style="font-family: Arial, Helvetica"> </font> </b> <font style="font-size: 10pt"> <font style="font-family: Arial, Helvetica"> </font> </font> <i> <font style="font-size: 10pt; font-family: 'Times New Roman', Times"> </font> </i> </div>  <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> The Company also holds financial instruments consisting of cash, accounts receivable, and accounts payable. The carrying amounts of cash, accounts receivable and accounts payable approximate fair value due to the short-term maturities of these instruments. The carrying value of the Company’s Revolver approximates fair value due to the variable interest rate terms. Derivative instruments are recorded at fair value as indicated in Note 10. </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> Cost method investments are evaluated for impairment quarterly. During 2010, the Company recorded a charge of $2.0 million in Selling, general and administrative expenses due to an <font style="white-space: nowrap">other-than-temporary</font> decline in the fair value of a cost method investment. This impairment charge was recognized in the Advanced Materials segment. As of December 31, 2009, the estimated fair value of this investment approximated the Company’s carrying value in the investment ($2.0 million). The decline in value was determined to be other <font style="white-space: nowrap">other-than-temporary</font> due to the Company’s reassessment of the fair value of the investment due, in part, to the investee’s inability to obtain permanent financing, which required the investee to delay and scale back its development plans. The Company determined that the fair value of the investment was zero based on Level 3 inputs. Level 3 inputs were used to determine the fair value of the investment as the investment was in a privately held entity without quoted market prices. To determine the fair value of the investments, the Company used earnings and cash flow forecasts of the entity. </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> Accounts receivable potentially subjects the Company to a concentration of credit risk. The Company maintains significant accounts receivable balances with several large customers. At December 31, 2010 the accounts receivable balance from our largest customer represented 6% of the Company’s net accounts receivable. Generally, the Company does not obtain security from its customers in support of accounts receivable. </div> <div style="margin-top: 6pt; font-size: 1pt"> </div> <div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"> Sales to Nichia Chemical Corporation represented approximately 14%, 16% and 22% of net sales in 2010, 2009 and 2008, respectively. No other customer individually represented more than 10% of net sales for any period presented. The loss of this customer could have a material adverse effect on the Company’s business, results of operations or financial position. Sales to the top three customers in the Battery Technologies segment represented approximately 50% of Battery Technologies’ net sales in 2010. The loss of one or more of these customers could have a material adverse effect on Battery Technologies’ business, results of operations or financial position. </div> </div>

</NonNumbericText>

<IsIndependantCurrency> false </IsIndependantCurrency>

<ShowCurrencySymbol> false </ShowCurrencySymbol>

<DisplayDateInUSFormat> false </DisplayDateInUSFormat>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

</Cell>

</Cells>

<Unit> Other </Unit>

<ElementDataType> us-types:textBlockItemType </ElementDataType>

<SimpleDataType> string </SimpleDataType>

<ElementDefenition> This element represents the disclosure related to the fair value measurement of assets and liabilities which includes [financial] instruments measured at fair value that are classified in stockholders' equity. Such assets and liabilities may be measured on a recurring or nonrecurring basis. The disclosures which may be required or desired include: (1) for assets and liabilities measured on a recurring basis, disclosure may include: (a) the fair value measurements at the reporting date; (b) the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3); (c) for fair value measurements using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (ii) purchases, sales, issuances, and settlements (net); (iii) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs); (d) the amount of the total gains or losses for the period in subparagraph (c) (i) above included in earnings (or changes in net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of where those unrealized gains or losses are reported in the statement of income (or activities); (e) the valuation technique(s) used to measure fair value and a discussion of changes in valuation techniques, if any, during the period and (2) for assets and liabilities that are measured at fair value on a nonrecurring basis (for example, impaired assets) disclosure may include, in addition to (a) above: (a) the reasons for the fair value measurements recorded; (b) the same as (b) above; (c) for fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used to develop the inputs; and (d) the valuation technique(s) used to measure fair value and a discussion of changes, if any, in the valuation technique(s) used to measure similar assets and/or liabilities in prior periods. </ElementDefenition>

<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 32 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 33 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 6 -Footnote 4 </ElementReferences>

<IsTotalLabel> false </IsTotalLabel>

<IsEPS> false </IsEPS>

<Label> Fair Value Disclosures </Label>

</Row>

</Rows>

<ReportName> Fair Value Disclosures </ReportName>

<MonetaryRoundingLevel> UnKnown </MonetaryRoundingLevel>

<SharesRoundingLevel> UnKnown </SharesRoundingLevel>

<PerShareRoundingLevel> UnKnown </PerShareRoundingLevel>

<ExchangeRateRoundingLevel> UnKnown </ExchangeRateRoundingLevel>

<HasCustomUnits> false </HasCustomUnits>

</InstanceReport>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/31/12  SEC                               UPLOAD¶     9/22/17    1:33K  Om Group Inc.
12/29/11  SEC                               UPLOAD¶     9/22/17    1:49K  Om Group Inc.

↑Top

Filing Submission 0000950123-11-017806 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Om Group Inc – ‘10-K’ for 12/31/10 – ‘XML.R19’

On: Thursday, 2/24/11, at 3:27pm ET · For: 12/31/10 · Accession #: 950123-11-17806 · File #: 1-12515

Previous ‘10-K’: ‘10-K’ on 2/25/10 for 12/31/09 · Next: ‘10-K’ on 2/28/12 for 12/31/11 · Latest: ‘10-K’ on 3/2/15 for 12/31/14 · 2 References: By: SEC – ‘UPLOAD’ on 1/31/12 By: SEC – ‘UPLOAD’ on 12/29/11

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘XML.R19’ — Fair Value Disclosures

This Financial Report is an XBRL XML File.

2 Subsequent Filings that Reference this Filing

Previous ‘10-K’: ‘10-K’ on 2/25/10 for 12/31/09 · Next: ‘10-K’ on 2/28/12 for 12/31/11 · Latest: ‘10-K’ on 3/2/15 for 12/31/14 · 2 References:

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents